VSee Health, Inc. (VSEE) Revenue History
Annual and quarterly revenue from 2020 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VSEE Revenue Growth
Revenue Breakdown (FY 2024)
VSEE's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
VSEE Revenue Analysis (2020–2024)
As of May 8, 2026, VSee Health, Inc. (VSEE) generated trailing twelve-month (TTM) revenue of $14.6 million, reflecting strong growth of +18.7% year-over-year. The most recent quarter (Q3 2025) recorded $4.0 million in revenue, up 17.4% sequentially.
Looking at the longer-term picture, VSEE's historical revenue data shows a 3-year CAGR of +12.4%. The company achieved its highest annual revenue of $10.4 million in 2024, representing a new all-time high.
Revenue diversification analysis shows VSEE's business is primarily driven by Subscription and Circulation (56%), Technology Service (27%), and Health Care, Patient Service (17%). With over half of revenue concentrated in Subscription and Circulation, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including TDOC (-1.5% YoY), AMWL (-30.3% YoY), and OPRX (+18.8% YoY), VSEE has underperformed the peer group in terms of revenue growth. Compare VSEE vs TDOC →
VSEE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| VSEECurrent | $15M | +18.7% | - | -596.4% | |
 TDOC | $2.5B | -1.5% | +18.3% | -10.4% | |
 AMWL | $249M | -30.3% | +0.3% | -42.2% | |
 OPRX | $109M | +18.8% | +20.4% | 10.7% | |
 TALK | $229M | +22.0% | +24.6% | 1.4% | |
 DOCS | $570M | +15.9% | +37.4% | 39.9% |
VSEE Historical Revenue Data (2020–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $10.4M | +80.7% | $7.2M | 68.9% | $-62,150,845 | -596.4% |
| 2023 | $5.8M | -9.6% | $3.8M | 66.5% | $-1,873,589 | -32.5% |
| 2022 | $6.4M | -13.1% | $4.8M | 75.8% | $-1,680,034 | -26.3% |
| 2021 | $7.3M | +7.8% | $5.9M | 80.7% | $252K | 3.4% |
| 2020 | $6.8M | - | $5.5M | 80.3% | $404K | 5.9% |
See VSEE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VSEE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VSEE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVSEE — Frequently Asked Questions
Quick answers to the most common questions about buying VSEE stock.
Is VSEE's revenue growth accelerating or slowing?
VSEE revenue is accelerating at +18.7% year-over-year, exceeding the 5-year CAGR of N/A. TTM revenue reached $15M. Growth momentum has increased versus prior periods.
What is VSEE's long-term revenue growth rate?
VSee Health, Inc.'s 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +18.7% is above this long-term average.
How is VSEE's revenue distributed by segment?
VSEE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2024 are available for download. Segment mix reveals concentration and diversification trends.